Bio-tech is hands-down the hottest sector in the market right now and seemingly every BIOTECH has a B/O rumor attached to it. But more importantly, Mr. Lewis said that WE would probably be buying another company before Y/E so this *Buy Out* rumor could just be $$$ for those that would be front-running the potential deal. Cookie-cutter Wall St. stuff. Having said this, you can't help but enjoy the increased valuation whatever the case.
Genuine or not, I'm surprised he doesn't have Shire on that suitor list. Maybe they've already spent their allocated acquisition money but they should/would be in on a potential Insmed B/O, in my opinion.